Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-005208-24Phase 3Terminated
A Phase 3 trial of human chorionic gonadotropin in female infertility, sponsored by Prof. Harry Siristatidis. Started May 2017; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-005208-24.